Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)

Baylor College of Medicine · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
car-t-cellsgene-therapy
refractory b-cell non-hodgkin lymphoma, refractory b-cell small lymphocytic lymphoma, relapsed adult all, relapsed cll, relapsed non hodgkin lymphoma, gene therapy, car t-cells, chimeric antigen receptor, b-cell malignancies, cd19, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 861685
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.